These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15845183

  • 21. Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria?
    Casiraghi M, Travaini LL, Maisonneuve P, Tessitore A, Brambilla D, Agoglia BG, Guarize J, Spaggiari L.
    Eur J Cardiothorac Surg; 2011 Apr; 39(4):e38-43. PubMed ID: 21242094
    [Abstract] [Full Text] [Related]

  • 22. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
    Yi JG, Marom EM, Munden RF, Truong MT, Macapinlac HA, Gladish GW, Sabloff BS, Podoloff DA.
    Radiology; 2005 Jul; 236(1):271-5. PubMed ID: 15987980
    [Abstract] [Full Text] [Related]

  • 23. Limited resection for clinical Stage IA non-small-cell lung cancers based on a standardized-uptake value index.
    Shiono S, Abiko M, Sato T.
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):e7-e12. PubMed ID: 23129358
    [Abstract] [Full Text] [Related]

  • 24. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
    Higashi K, Ueda Y, Arisaka Y, Sakuma T, Nambu Y, Oguchi M, Seki H, Taki S, Tonami H, Yamamoto I.
    J Nucl Med; 2002 Jan; 43(1):39-45. PubMed ID: 11801701
    [Abstract] [Full Text] [Related]

  • 25. Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.
    Mak RH, Digumarthy SR, Muzikansky A, Engelman JA, Shepard JA, Choi NC, Sequist LV.
    Oncologist; 2011 Jan; 16(3):319-26. PubMed ID: 21339258
    [Abstract] [Full Text] [Related]

  • 26. Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer.
    Geiger GA, Kim MB, Xanthopoulos EP, Pryma DA, Grover S, Plastaras JP, Langer CJ, Simone CB, Rengan R.
    Clin Lung Cancer; 2014 Jan; 15(1):79-85. PubMed ID: 24238934
    [Abstract] [Full Text] [Related]

  • 27. Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation.
    Lee EY, Khong PL, Lee VH, Qian W, Yu X, Wong MP.
    Clin Nucl Med; 2015 Mar; 40(3):e190-5. PubMed ID: 25608155
    [Abstract] [Full Text] [Related]

  • 28. Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers.
    Shiono S, Abiko M, Sato T.
    J Thorac Oncol; 2011 Jan; 6(1):43-7. PubMed ID: 21079522
    [Abstract] [Full Text] [Related]

  • 29. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group.
    Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, Verbeken EK, Deneffe GJ, Mortelmans LA, Demedts MG.
    J Clin Oncol; 1999 Oct; 17(10):3201-6. PubMed ID: 10506619
    [Abstract] [Full Text] [Related]

  • 30. [Correlation between SUV of (18)F-FDG PET-CT and the expression of GLUT1, MVD and Ki67 in non-small cell lung cancer].
    Duan Y, Yu LJ, Lu PO, Wang WZ.
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):764-7. PubMed ID: 19173807
    [Abstract] [Full Text] [Related]

  • 31. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
    Tournoy KG, Maddens S, Gosselin R, Van Maele G, van Meerbeeck JP, Kelles A.
    Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098
    [Abstract] [Full Text] [Related]

  • 32. Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases.
    Al-Sarraf N, Gately K, Lucey J, Aziz R, Doddakula K, Wilson L, McGovern E, Young V.
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):892-7. PubMed ID: 18722132
    [Abstract] [Full Text] [Related]

  • 33. Risk factors for N2 metastasis in patients with non-small-cell lung cancer: multivariate analyses of 18F-FDG PET/CT data.
    Su M, Li Y, Li F, Li L, Tian R.
    Nucl Med Commun; 2014 Sep; 35(9):916-21. PubMed ID: 24785010
    [Abstract] [Full Text] [Related]

  • 34. Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer.
    Park SY, Cho A, Yu WS, Lee CY, Lee JG, Kim DJ, Chung KY.
    J Nucl Med; 2015 Jan; 56(1):45-9. PubMed ID: 25525185
    [Abstract] [Full Text] [Related]

  • 35. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H, Rafla S, Parikh K, Mokhtar B, Goswami G, Kambam S, Abdel-Dayem H, Guirguis A, Ross P, Evola A.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1016-23. PubMed ID: 15979817
    [Abstract] [Full Text] [Related]

  • 36. Inter-comparison of 18F-FDG PET/CT standardized uptake values in Korea.
    Park HH, Park DS, Kweon DC, Lee SB, Oh KB, Lee JD, Jin GH.
    Appl Radiat Isot; 2011 Jan 15; 69(1):241-6. PubMed ID: 20933430
    [Abstract] [Full Text] [Related]

  • 37. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S.
    Radiology; 2005 Sep 15; 236(3):1011-9. PubMed ID: 16014441
    [Abstract] [Full Text] [Related]

  • 38. Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.
    de Jong WK, van der Heijden HF, Pruim J, Dalesio O, Oyen WJ, Groen HJ.
    J Thorac Oncol; 2007 Nov 15; 2(11):1007-12. PubMed ID: 17975491
    [Abstract] [Full Text] [Related]

  • 39. Interobserver and intraobserver variability of standardized uptake value measurements in non-small-cell lung cancer.
    Marom EM, Munden RF, Truong MT, Gladish GW, Podoloff DA, Mawlawi O, Broemeling LD, Bruzzi JF, Macapinlac HA.
    J Thorac Imaging; 2006 Aug 15; 21(3):205-12. PubMed ID: 16915065
    [Abstract] [Full Text] [Related]

  • 40. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.
    Eur J Cardiothorac Surg; 2009 Sep 15; 36(3):440-5. PubMed ID: 19464906
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.